Answers are grounded in this paper and cite their sources.
Lithium is an established treatment for bipolar disorder and an augmenting agent for treatment-resistant depression. Despite awareness of renal adverse effects, including chronic kidney disease, for the past five decades, there has been a lack of research evidence. This has led to debates around the existence and magnitude of the risk. This article discusses the current evidence base regarding the link between lithium and chronic kidney disease, monitoring of renal functions and its clinical implications.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: